InnerScope Hearing Technologies (OTC: INND) Partners with Giant Eagle to Deploy Hearing Screening Kiosks
01 déc. 2021 08h00 HE
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
InnerScope Hearing Technologies (OTC: INND) Completes Acquisition of Hearing Assist
29 nov. 2021 08h00 HE
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
InnerScope Hearing Technologies (OTC: INND) Partners with Food City Pharmacy to Offer Free Self-Check Hearing Screenings Kiosk
22 nov. 2021 08h00 HE
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss
22 nov. 2021 07h30 HE
|
Decibel Therapeutics, Inc.
Collaboration gene therapy product candidate, DB-OTO, on track to enter clinical testing in 2022; two additional gene therapy programs for congenital, monogenic forms of hearing loss in development...
$175.73Mn by 2028 Medical Audiometer Devices Market Size Lead by Hybrid Audiometers (4.4% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
22 nov. 2021 06h42 HE
|
The Insight Partners
New York, Nov. 22, 2021 (GLOBE NEWSWIRE) -- According to our new research study on Medical Audiometer Devices Market Size, Share, Revenue, Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Otonomy to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
16 nov. 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...
CaptionCall Salutes Military Veterans and Families
10 nov. 2021 17h05 HE
|
CaptionCall, LLC
SALT LAKE CITY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- CaptionCall salutes the nearly 19 million U.S. military veterans for their service to the nation and recognizes the military families who served...
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10 nov. 2021 16h18 HE
|
Otonomy, Inc.
OTO-313 Phase 2 trial in tinnitus ongoing with results expected in mid-2022Enrollment nearly complete in OTO-413 Phase 2a cohort in hearing loss with results moved forward to early in second quarter...
Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
10 nov. 2021 07h30 HE
|
Decibel Therapeutics, Inc.
- Received Orphan Drug and Rare Pediatric Disease designations for DB-OTO for the treatment of otoferlin-related congenital hearing loss – - On track for key 2022 milestones including submission of...
Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
08 nov. 2021 07h00 HE
|
Decibel Therapeutics, Inc.
BOSTON, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...